204
Views
18
CrossRef citations to date
0
Altmetric
Original Articles Clinical

Differences in germinal centre and non-germinal center phenotype in gastric and intestinal diffuse large B-cell lymphomas

, & , MD
Pages 1717-1723 | Received 25 Feb 2008, Accepted 27 May 2008, Published online: 01 Jul 2009

References

  • Harris N L, Jaffe E S, Diebold J, Flandrin G, Muller-Hermelink H K, Vardiman J, et al. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology 2000; 36: 69–86
  • Harris N L, Jaffe E S, Stein H, Banks P M, Chan J K, Cleary M L, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392
  • d'Amore F, Brincker H, Gronbaek K, Thorling K, Pedersen M, Jensen M K, et al. Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group. J Clin Oncol 1994; 12: 1673–1684
  • Hans C P, Weisenburger D D, Greiner T C, Gascoyne R D, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004; 103: 275–282
  • Chang C C, McClintock S, Cleveland R P, Trzpuc T, Vesole D H, Logan B, et al. Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma. Am J Surg Pathol 2004; 28: 464–470
  • Colomo L, Lopez-Guillermo A, Perales M, Rives S, Martinez A, Bosch F, et al. Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. Blood 2003; 101: 78–84
  • Winter J N, Weller E A, Horning S J, Krajewska M, Variakojis D, Habermann T M, et al. Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study. Blood 2006; 107: 4207–4213
  • Yamauchi A, Fujita S, Ikeda J, Nakamichi I, Fukuhara S, Hino M, et al. Diffuse large B-cell lymphoma in the young in Japan: a study by the Osaka Lymphoma Study Group. Am J Hematol 2007; 82: 893–897
  • Go J H, Yang W I, Ree H J. CD10 expression in primary intestinal large B-cell lymphomas: its clinical significance. Arch Pathol Lab Med 2002; 126: 956–960
  • Alizadeh A A, Eisen M B, Davis R E, Ma C, Lossos I S, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503–511
  • Ibrahim E M, Ezzat A A, El-Weshi A N, Martin J M, Khafaga Y M, Al Rabih W, et al. Primary intestinal diffuse large B-cell non-Hodgkin's lymphoma: clinical features, management, and prognosis of 66 patients. Ann Oncol 2001; 12: 53–58
  • Wong M T, Eu K W. Primary colorectal lymphomas. Colorectal Dis 2006; 8: 586–591
  • Connor J, Ashton-Key M. Gastric and intestinal diffuse large B-cell lymphomas are clinically and immunophenotypically different. An immunohistochemical and clinical study. Histopathology 2007; 51: 697–703
  • Greene F L, Page D L, Fleming I D, Fritz A G, Balch C M, Haller D G, et al. AJCC Cancer Staging Manual6th ed. Springer-Verlag, New York 2002
  • Ponzoni M, Ferreri A J, Pruneri G, Pozzi B, Dell'Oro S, Pigni A, et al. Prognostic value of bcl-6, CD10 and CD38 immunoreactivity in stage I-II gastric lymphomas: identification of a subset of CD10+ large B-cell lymphomas with a favorable outcome. Int J Cancer 2003; 106: 288–291
  • Lopez-Guillermo A, Colomo L, Jimenez M, Bosch F, Villamor N, Aranillas L, et al. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin. J Clin Oncol 2005; 23: 2797–2804
  • Muris J J, Meijer C J, Vos W, van Krieken J H, Jiwa N M, Ossenkoppele G J, et al. Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma. J Pathol 2006; 208: 714–723
  • Banks P M. Gastrointestinal lymphoproliferative disorders. Histopathology 2007; 50: 42–54
  • Yoshino T, Miyake K, Ichimura K, Mannami T, Ohara N, Hamazaki S, et al. Increased incidence of follicular lymphoma in the duodenum. Am J Surg Pathol 2000; 24: 688–693
  • Shia J, Teruya-Feldstein J, Pan D, Hegde A, Klimstra D S, Chiganti R S, et al. Primary follicular lymphoma of the gastrointestinal tract: a clinical and pathologic study of 26 cases. Am J Surg Pathol 2002; 26: 216–224
  • LeBrun D P, Kamel O W, Cleary M L, Dorfman R F, Warnke R A. Follicular lymphomas of the gastrointestinal tract. Pathologic features in 31 cases and bcl-2 oncogenic protein expression. Am J Pathol 1992; 140: 1327–1335
  • Farinha P, Gascoyne R D. Helicobacter pylori and MALT lymphoma. Gastroenterology 2005; 128: 1579–1605
  • Isaacson P G, Du M Q. Gastrointestinal lymphoma: where morphology meets molecular biology. J Pathol 2005; 205: 255–274
  • Iwano M, Watanabe N, Matsushima Y, Seno H, Oki K, Sakurai T, et al. Rapid development of diffuse large B-Cell lymphoma after successful eradication of Helicobacter pylori for gastric MALT lymphoma. Am J Gastroenterol 2006; 101: 2878–2883
  • Ahmad A, Govil Y, Frank B B. Gastric mucosa-associated lymphoid tissue lymphoma. Am J Gastroenterol 2003; 98: 975–986
  • Barth T F, Barth C A, Kestler H A, Michl P, Weniger M A, Buchholtz M, et al. Transcriptional profiling suggests that secondary and primary large B-cell lymphomas of the gastrointestinal (GI) tract are blastic variants of GI marginal zone lymphoma. J Pathol 2007; 211: 305–313
  • Takeshita M, Iwashita A, Kurihara K, Ikejiri K, Higashi H, Udoh T, et al. Histologic and immunohistologic findings and prognosis of 40 cases of gastric large B-cell lymphoma. Am J Surg Pathol 2000; 24: 1641–1649
  • Nakamura S, Yao T, Aoyagi K, Iida M, Fujishima M, Tsuneyoshi M. Helicobacter pylori and primary gastric lymphoma. A histopathologic and immunohistochemical analysis of 237 patients. Cancer 1997; 79: 3–11

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.